• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素硫酸蛋白聚糖和低密度脂蛋白受体对肝残余脂蛋白的清除依赖于小鼠的饮食条件。

Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.

机构信息

Department of Cellular and Molecular Medicine University of California San Diego, La Jolla, California, USA.

Department of Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, California, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2065-74. doi: 10.1161/ATVBAHA.113.301637. Epub 2013 Jul 11.

DOI:10.1161/ATVBAHA.113.301637
PMID:23846497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3821931/
Abstract

OBJECTIVE

Chylomicron and very low-density lipoprotein remnants are cleared from the circulation in the liver by heparan sulfate proteoglycan (HSPG) receptors (syndecan-1), the low-density lipoprotein receptor (LDLR), and LDLR-related protein-1 (LRP1), but the relative contribution of each class of receptors under different dietary conditions remains unclear.

APPROACH AND RESULTS

Triglyceride-rich lipoprotein clearance was measured in AlbCre(+)Ndst1(f/f), Ldlr(-/-), and AlbCre(+)Lrp1(f/f) mice and mice containing combinations of these mutations. Triglyceride measurements in single and double mutant mice showed that HSPGs and LDLR dominate clearance under fasting conditions and postprandial conditions, but LRP1 contributes significantly when LDLR is absent. Mice lacking hepatic expression of all 3 receptors (AlbCre(+)Ndst1(f/f) Lrp1(f/f) Ldlr(-/-)) displayed dramatic hyperlipidemia (870 ± 270 mg triglyceride/dL; 1300 ± 350 mg of total cholesterol/dL) and exhibited persistent elevated postprandial triglyceride levels because of reduced hepatic clearance. Analysis of the particles accumulating in mutants showed that HSPGs preferentially clear a subset of small triglyceride-rich lipoproteins (≈ 20-40 nm diameter), whereas LDLR and LRP1 clear larger particles (≈ 40-60 nm diameter). Finally, we show that HSPGs play a major role in clearance of triglyceride-rich lipoproteins in mice fed normal chow or under postprandial conditions but seem to play a less significant role on a high-fat diet.

CONCLUSIONS

These data show that HSPGs, LDLR, and LRP1 clear distinct subsets of particles, that HSPGs work independently of LDLR and LRP1, and that HSPGs, LDLR, and LRP1 are the 3 major hepatic triglyceride-rich lipoprotein clearance receptors in mice.

摘要

目的

乳糜微粒和极低密度脂蛋白残粒通过硫酸乙酰肝素蛋白聚糖(HSPG)受体(连接蛋白-1)、低密度脂蛋白受体(LDLR)和 LDLR 相关蛋白-1(LRP1)从循环中清除,但在不同饮食条件下,每种受体的相对贡献仍不清楚。

方法和结果

在 AlbCre(+)Ndst1(f/f)、Ldlr(-/-)和 AlbCre(+)Lrp1(f/f)小鼠以及含有这些突变组合的小鼠中测量富含甘油三酯的脂蛋白清除率。在单突变和双突变小鼠中进行甘油三酯测量表明,HSPG 和 LDLR 在空腹和餐后条件下主导清除,而在 LDLR 缺失时 LRP1 贡献显著。缺乏肝脏表达所有 3 种受体(AlbCre(+)Ndst1(f/f) Lrp1(f/f) Ldlr(-/-))的小鼠表现出明显的高脂血症(870 ± 270 mg 甘油三酯/dL;1300 ± 350 mg 总胆固醇/dL),并由于肝清除减少而表现出持续升高的餐后甘油三酯水平。对在突变体中积累的颗粒进行分析表明,HSPG 优先清除一小部分富含甘油三酯的小脂蛋白(≈20-40nm 直径),而 LDLR 和 LRP1 则清除较大的颗粒(≈40-60nm 直径)。最后,我们表明 HSPG 在正常饲料喂养或餐后条件下的小鼠中清除富含甘油三酯的脂蛋白中起主要作用,但在高脂肪饮食中似乎作用较小。

结论

这些数据表明 HSPG、LDLR 和 LRP1 清除不同的颗粒亚群,HSPG 独立于 LDLR 和 LRP1 发挥作用,HSPG、LDLR 和 LRP1 是小鼠中 3 种主要的肝脏富含甘油三酯的脂蛋白清除受体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/2da3fc7e41f2/nihms-512507-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/944d3c3a47db/nihms-512507-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/0e407dea7d10/nihms-512507-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/5c286ce56810/nihms-512507-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/e21ddd45fcd1/nihms-512507-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/2da3fc7e41f2/nihms-512507-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/944d3c3a47db/nihms-512507-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/0e407dea7d10/nihms-512507-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/5c286ce56810/nihms-512507-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/e21ddd45fcd1/nihms-512507-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abf0/3821931/2da3fc7e41f2/nihms-512507-f0005.jpg

相似文献

1
Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.肝素硫酸蛋白聚糖和低密度脂蛋白受体对肝残余脂蛋白的清除依赖于小鼠的饮食条件。
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2065-74. doi: 10.1161/ATVBAHA.113.301637. Epub 2013 Jul 11.
2
The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.衔接蛋白 PID1 调节餐后富含甘油三酯的脂蛋白的受体依赖性内吞作用。
Mol Metab. 2018 Oct;16:88-99. doi: 10.1016/j.molmet.2018.07.010. Epub 2018 Jul 30.
3
Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance.胰岛素刺激肝脏低密度脂蛋白受体相关蛋白1(LRP1)以增加餐后脂蛋白清除率。
Atherosclerosis. 2009 May;204(1):105-11. doi: 10.1016/j.atherosclerosis.2008.07.046. Epub 2008 Aug 29.
4
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.载脂蛋白C-III通过低密度脂蛋白家族受体抑制富含甘油三酯的脂蛋白的清除。
J Clin Invest. 2016 Aug 1;126(8):2855-66. doi: 10.1172/JCI86610. Epub 2016 Jul 11.
5
Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants.删除淋巴管生成和血管生成生长因子 VEGF-D 可导致严重高脂血症和乳糜微粒残粒清除延迟。
Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2327-2337. doi: 10.1161/ATVBAHA.118.311549.
6
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.Syndecan-1是介导小鼠肝脏清除富含甘油三酯脂蛋白的主要硫酸乙酰肝素蛋白聚糖。
J Clin Invest. 2009 Nov;119(11):3236-45. doi: 10.1172/JCI38251. Epub 2009 Oct 1.
7
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.乙酰肝素 2-O-磺基转移酶对于富含甘油三酯的脂蛋白的清除是必需的。
J Biol Chem. 2010 Jan 1;285(1):286-94. doi: 10.1074/jbc.M109.063701. Epub 2009 Nov 4.
8
Cargo-Specific Role for Retriever Subunit VPS26C in Hepatocyte Lipoprotein Receptor Recycling to Control Postprandial Triglyceride-Rich Lipoproteins.载脂蛋白特异性 VPS26C 亚基在肝细胞脂蛋白受体回收中的作用,以控制餐后富含甘油三酯的脂蛋白。
Arterioscler Thromb Vasc Biol. 2023 Jan;43(1):e29-e45. doi: 10.1161/ATVBAHA.122.318169. Epub 2022 Nov 10.
9
The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.西洛他唑的调脂作用可能是通过调节肝低密度脂蛋白受体相关蛋白 1(LRP1)的表达来实现的。
Metabolism. 2014 Jan;63(1):112-9. doi: 10.1016/j.metabol.2013.09.006. Epub 2013 Oct 17.
10
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.肝脏硫酸乙酰肝素蛋白聚糖独立于低密度脂蛋白受体家族成员介导富含甘油三酯脂蛋白的清除。
J Clin Invest. 2007 Jan;117(1):153-64. doi: 10.1172/JCI29154.

引用本文的文献

1
Kupffer cells dictate hepatic responses to the atherogenic dyslipidemic insult.枯否细胞决定肝脏对动脉粥样硬化性血脂异常损伤的反应。
Nat Cardiovasc Res. 2024 Mar;3(3):356-371. doi: 10.1038/s44161-024-00448-6. Epub 2024 Mar 11.
2
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets.揭示 VLDL 的奥秘:探索其作为治疗靶点的产生、细胞内运输和代谢。
Lipids Health Dis. 2024 Jan 12;23(1):14. doi: 10.1186/s12944-023-01993-y.
3
Regulation of autophagy, lipid metabolism, and neurodegenerative pathology by heparan sulfate proteoglycans.

本文引用的文献

1
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans.载脂蛋白 E 和 AV 通过肝脏蛋白聚糖介导脂蛋白清除。
J Clin Invest. 2013 Jun;123(6):2742-51. doi: 10.1172/JCI67398. Epub 2013 May 8.
2
Mast cells limit extracellular levels of IL-13 via a serglycin proteoglycan-serine protease axis.肥大细胞通过硫酸乙酰肝素蛋白聚糖-丝氨酸蛋白酶轴限制细胞外的 IL-13 水平。
Biol Chem. 2012 Dec;393(12):1555-67. doi: 10.1515/hsz-2012-0189.
3
Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.
硫酸乙酰肝素蛋白聚糖对自噬、脂质代谢和神经退行性病理的调节作用。
Front Genet. 2023 Jan 9;13:1012706. doi: 10.3389/fgene.2022.1012706. eCollection 2022.
4
Heparin Does Not Regulate Circulating Human PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) in a General Population-Brief Report.肝素在普通人群中并不调节循环人 PCSK9(前蛋白转化酶枯草溶菌素 9)-简短报告。
Arterioscler Thromb Vasc Biol. 2023 Feb;43(2):352-358. doi: 10.1161/ATVBAHA.122.318556. Epub 2022 Dec 8.
5
Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding.前蛋白转化酶枯草溶菌素9(PCSK9)前结构域和C末端结构域中的致病性功能获得性突变会抑制低密度脂蛋白(LDL)结合。
Front Physiol. 2022 Sep 14;13:960272. doi: 10.3389/fphys.2022.960272. eCollection 2022.
6
Lipoprotein sialylation in atherosclerosis: Lessons from mice.载脂蛋白唾液酸化在动脉粥样硬化中的作用:来自小鼠的启示。
Front Endocrinol (Lausanne). 2022 Sep 6;13:953165. doi: 10.3389/fendo.2022.953165. eCollection 2022.
7
Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering.经介入肝 apoC-III 敲低治疗可通过降低甘油三酯来改善动脉粥样硬化斑块的稳定性和重塑。
JCI Insight. 2022 Jul 8;7(13):e158414. doi: 10.1172/jci.insight.158414.
8
Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.预处理血脂水平是接受安罗替尼治疗的晚期 NSCLC 患者的预后因素。
Lipids Health Dis. 2021 Nov 20;20(1):165. doi: 10.1186/s12944-021-01596-5.
9
Recruiting a transcription factor in the liver to prevent atherosclerosis.招募一种肝脏中的转录因子以预防动脉粥样硬化。
J Clin Invest. 2021 Nov 15;131(22). doi: 10.1172/JCI154677.
10
Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases.了解系统性高密度脂蛋白颗粒向脑和血管细胞的交换对神经退行性疾病具有诊断和治疗意义。
Front Physiol. 2021 Sep 6;12:700847. doi: 10.3389/fphys.2021.700847. eCollection 2021.
人肝细胞表面硫酸乙酰肝素蛋白聚糖-1 的脱落改变极低密度脂蛋白的清除。
Hepatology. 2012 Jan;55(1):277-86. doi: 10.1002/hep.24626. Epub 2011 Dec 6.
4
Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.肝内乙酰肝素硫酸蛋白聚糖与富含甘油三酯的脂蛋白的内吞清除。
Prog Mol Biol Transl Sci. 2010;93:213-33. doi: 10.1016/S1877-1173(10)93010-X.
5
Recent insights into factors affecting remnant lipoprotein uptake.近期对影响残余脂蛋白摄取因素的深入了解。
Curr Opin Lipidol. 2010 Jun;21(3):218-28. doi: 10.1097/MOL.0b013e328338cabc.
6
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.乙酰肝素 2-O-磺基转移酶对于富含甘油三酯的脂蛋白的清除是必需的。
J Biol Chem. 2010 Jan 1;285(1):286-94. doi: 10.1074/jbc.M109.063701. Epub 2009 Nov 4.
7
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.Syndecan-1是介导小鼠肝脏清除富含甘油三酯脂蛋白的主要硫酸乙酰肝素蛋白聚糖。
J Clin Invest. 2009 Nov;119(11):3236-45. doi: 10.1172/JCI38251. Epub 2009 Oct 1.
8
Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.通过定量聚糖还原同位素标记检测到的糖胺聚糖精细结构的进化差异。
J Biol Chem. 2008 Nov 28;283(48):33674-84. doi: 10.1074/jbc.M804288200. Epub 2008 Sep 24.
9
Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice.脂肪分解刺激脂蛋白受体:小鼠高脂血症、体重增加和动脉粥样硬化之间的新型分子联系。
J Biol Chem. 2008 Sep 12;283(37):25650-25659. doi: 10.1074/jbc.M801027200. Epub 2008 Jul 21.
10
Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.空腹和非空腹血清甘油三酯与心血管疾病的关联以及残粒样脂蛋白和小而密低密度脂蛋白的作用
Curr Opin Lipidol. 2008 Aug;19(4):355-61. doi: 10.1097/MOL.0b013e328304b63c.